HLA signatures as pathophysiological discriminants of microscopic colitis subtypes.
GWAS
HLA
Microscopic colitis
collagenous colitis
genetics
Journal
Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676
Informations de publication
Date de publication:
28 Sep 2023
28 Sep 2023
Historique:
received:
17
05
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
aheadofprint
Résumé
Microscopic colitis (MC) is currently regarded as an inflammatory bowel disease that manifests as two subtypes: collagenous colitis (CC) and lymphocytic colitis (LC). Whether these represent a clinical continuum or distinct entities is, however, an open question. Genetic investigations may contribute important insight into their respective pathophysiology. We conducted a GWAS meta-analysis in 1,498 CC and 373 LC patients and 13,487 controls from Europe and US, combined with publicly available MC GWAS data from UK Biobank and FinnGen (2,599 MC cases and 552,343 controls in total). HLA alleles and polymorphic residues were imputed and tested for association, including conditional analyses for the identification of key causative variants and residues. Genetic correlations with other traits and diagnoses were also studied. We detected strong HLA association with CC, and conditional analyses highlighted the DRB1*03:01 allele and its residues Y26, N77 and R74 as key to this association (best P=1.4×10 -23, OR=1.96). Nominally significant genetic correlations were detected between CC and Pneumonia (rg=0.77; P=0.048) and oesophageal diseases (rg=0.45, P=0.023). An additional locus was identified in MC GWAS analyses near the CLEC16A and RMI2 genes on chromosome 16 (rs35099084, P=2.0×10 -8, OR=1.31). No significant association was detected for LC. Our results suggest CC and LC have distinct pathophysiological underpinnings, characterised by an HLA predisposing role only in CC. This challenges existing classifications, eventually calling for a re-evaluation of the utility of MC umbrella definitions.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
Microscopic colitis (MC) is currently regarded as an inflammatory bowel disease that manifests as two subtypes: collagenous colitis (CC) and lymphocytic colitis (LC). Whether these represent a clinical continuum or distinct entities is, however, an open question. Genetic investigations may contribute important insight into their respective pathophysiology.
METHODS
METHODS
We conducted a GWAS meta-analysis in 1,498 CC and 373 LC patients and 13,487 controls from Europe and US, combined with publicly available MC GWAS data from UK Biobank and FinnGen (2,599 MC cases and 552,343 controls in total). HLA alleles and polymorphic residues were imputed and tested for association, including conditional analyses for the identification of key causative variants and residues. Genetic correlations with other traits and diagnoses were also studied.
RESULTS
RESULTS
We detected strong HLA association with CC, and conditional analyses highlighted the DRB1*03:01 allele and its residues Y26, N77 and R74 as key to this association (best P=1.4×10 -23, OR=1.96). Nominally significant genetic correlations were detected between CC and Pneumonia (rg=0.77; P=0.048) and oesophageal diseases (rg=0.45, P=0.023). An additional locus was identified in MC GWAS analyses near the CLEC16A and RMI2 genes on chromosome 16 (rs35099084, P=2.0×10 -8, OR=1.31). No significant association was detected for LC.
CONCLUSION
CONCLUSIONS
Our results suggest CC and LC have distinct pathophysiological underpinnings, characterised by an HLA predisposing role only in CC. This challenges existing classifications, eventually calling for a re-evaluation of the utility of MC umbrella definitions.
Identifiants
pubmed: 37768647
pii: 7285336
doi: 10.1093/ecco-jcc/jjad165
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.